Patent · US Active

Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery

US11246838B2 · kind B2 · utility

1Cited by
12References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 4, 2014
Grant dateFeb 15, 2022
Priority date
Expiry dateMar 4, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for sustained delivery of an agent to an ocular organ in a subject, comprising topically delivering to the ocular surface a liquid thermoresponsive hydrogel comprising agent-loaded polymer microparticles, wherein the agent is sustainably released for a period of at least five days.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.